Health risks and benefits 3 years after stopping randomized treatment with estrogen and progestin.
Heiss G; Wallace R; Anderson GL; Aragaki A; Beresford SA; Brzyski R; Chlebowski RT; Gass M; LaCroix A; Manson JE; Prentice RL; Rossouw J; Stefanick ML; JAMA, 2008, vol. 299, issue 9, p 1036, ISSN 15383598. ISBN 15383598.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef